Free Trial

Public Employees Retirement System of Ohio Has $1.16 Million Stock Position in Simulations Plus, Inc. (NASDAQ:SLP)

Simulations Plus logo with Computer and Technology background

Public Employees Retirement System of Ohio lifted its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 58.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 41,692 shares of the technology company's stock after purchasing an additional 15,399 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.21% of Simulations Plus worth $1,163,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Conestoga Capital Advisors LLC boosted its stake in Simulations Plus by 15.0% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company's stock worth $62,090,000 after purchasing an additional 290,414 shares during the period. Ameriprise Financial Inc. raised its holdings in Simulations Plus by 16.7% during the fourth quarter. Ameriprise Financial Inc. now owns 607,902 shares of the technology company's stock valued at $16,954,000 after buying an additional 86,868 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in Simulations Plus by 7,753.3% in the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock worth $15,141,000 after purchasing an additional 535,986 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Simulations Plus by 6.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 419,241 shares of the technology company's stock worth $11,693,000 after buying an additional 24,266 shares during the period. Finally, Royce & Associates LP grew its stake in Simulations Plus by 56.6% in the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock valued at $10,369,000 after buying an additional 134,381 shares during the last quarter. Institutional investors own 78.08% of the company's stock.

Analyst Ratings Changes

A number of research firms have weighed in on SLP. William Blair reissued an "outperform" rating on shares of Simulations Plus in a research report on Tuesday. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Finally, KeyCorp increased their target price on Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. Two research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $50.00.

Get Our Latest Analysis on SLP

Simulations Plus Stock Performance

Shares of SLP traded up $0.42 during trading hours on Thursday, reaching $27.97. 164,345 shares of the company traded hands, compared to its average volume of 223,557. The stock's fifty day moving average is $30.56 and its 200 day moving average is $30.37. Simulations Plus, Inc. has a 1-year low of $23.01 and a 1-year high of $50.11. The stock has a market cap of $562.48 million, a P/E ratio of 70.30 and a beta of 1.10.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The company had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business's revenue was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.20 EPS. On average, equities research analysts predict that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Insider Activity

In other news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the completion of the transaction, the director now owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. The trade was a 0.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 19.40% of the company's stock.

Simulations Plus Profile

(Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Featured Stories

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Should You Invest $1,000 in Simulations Plus Right Now?

Before you consider Simulations Plus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.

While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines